A 1-for-200 reverse split at OTCQB level is a distress signal — the stock price was likely pennies or sub-penny. Monitor for potential delisting if the post-split price fails to hold above $0.01 or if the company cannot maintain OTCQB continued listing standards. The split does not change fundamentals; watch for a subsequent dilutive offering or going-concern warning.
Price Chart
Executive Summary
Galera Therapeutics announced a 1-for-200 reverse stock split, effective July 12, 2026, with split-adjusted trading starting July 13, 2026. The extreme 200:1 ratio signals a last-resort effort to maintain OTCQB listing compliance, reflecting severe financial distress.
Key Facts
- Board approved a 1-for-200 reverse stock split
- Effective July 12, 2026 at 11:59 p.m. ET; split-adjusted trading begins July 13, 2026
- No fractional shares will be issued; cash paid in lieu of fractional shares
- Outstanding stock options and warrants will be proportionally adjusted with corresponding exercise price increases
- Shares available under equity incentive plans will be reduced proportionally
- Stock trades on OTCQB Market under symbol GRTX
Financial Impact
Extreme 200:1 reverse split — no specific dollar amounts disclosed in filing; the ratio is among the highest observed for OTC-listed microcaps, indicating severe stock price deterioration
Risk Factors
- Post-split price may fail to sustain above OTCQB minimum bid price requirements
- Extreme reverse split often precedes further dilution via equity offerings
- No revenue or pipeline catalysts disclosed — company may be running low on cash
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-296981 |
| Document: 0001193125-26-296981-index-headers.html | 0001193125-26-296981 |
| Document: 0001193125-26-296981-index.html | 0001193125-26-296981 |
| Document: 0001193125-26-296981.txt | 0001193125-26-296981 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 11w ago | EFFECT | — | awaiting T+20 | — | — |
Aug 4, 2026 11w ago | 15-12G | — | awaiting T+20 | — | — |
Aug 3, 2026 12w ago | 8-K | — | awaiting T+20 | — | — |
Jul 13, 2026 15w ago | 8-K | $16.39 | awaiting T+20 | — | — |
Jul 7, 2026 15w ago | 8-K | $17.80 | awaiting T+20 | — | — |
May 21, 2026 22w ago | 425 | $0.1000 $0.0910 | ▼ −9.00% | ▼ −7.58% | — |
May 19, 2026 22w ago | 8-K | $0.1010 $0.0857 | ▲ +15.15% | ▲ +15.89% | — |
Apr 22, 2026 26w ago | 425 | $20.00 $20.20 | ▲ +1.00% | ▼ −3.22% | — |
Apr 22, 2026 26w ago | 425 | $20.00 $20.20 | ▲ +1.00% | ▼ −3.22% | — |
Apr 14, 2026 27w ago | Press Release | $0.0790 $0.1000 | ▼ −26.58% | ▼ −20.29% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers